Hennig_GRC-2023

Loading viewer...

whitepaper

Format: PDF whitepaper

This document presents research on a novel mRNA therapy by ReCode Therapeutics aimed at treating Primary Ciliary Dyskinesia, addressing a significant medical need.

Browse all whitepapers →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from ReCode Therapeutics

View all →

presentation

Similar whitepapers from other companies

Browse all →

whitepaper

Globalstar

whitepaper

Bullhorn